Singapore Institute of Advanced Medicine Holdings (SAM) has partnered with ProNova Solutions on the setting-up of a new proton therapy facility in Singapore.

The new cancer and proton centre, which involves the investment of around $100m, will be constructed at the Biopolis Campus in the country.

SAM founder and chairman Djeng Shih Kien said: "We believe proton therapy is a significant step forward in our treatment of cancer and ProNova has proven to be the best partner with next generation technology."

As part of the deal, ProNova will equip the new centre with two superconducting gantry proton treatment rooms, including an additional room for research.

"The new developments in proton therapy and other cancer treatment technologies…will be a major step in redefining the future of cancer treatment."

Each treatment room features Fast Scanning IMPT technology with integrated 3D imaging, which offers edge pencil beam delivery with imaging capability. It allows physicians and therapists to minimise collateral damage to healthy tissue and increase dosage to the tumour.

The company will also install its SC360 proton therapy system at the new outpatient cancer centre.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

ProNova Solutions chairman and CEO Terry Douglass said: "We look forward to providing our unique total solutions offerings and sharing our proton therapy knowledge and clinical experience with SAM’s staff.

"We believe that the new developments in proton therapy and other cancer treatment technologies accomplished at the SAM ProNova Biopolis Cancer Center will be a major step in redefining the future of cancer treatment."

Biopolis campus also houses the research and development centres of pharma companies such as Abbott, GlaxoSmithKline, Lilly, Novartis, Schering-Plough and Takeda.

Proton therapy is a form of radiation therapy, which uses a single beam of high-energy protons for the treatment of different types of cancers.